News for Healthier Living

Patients With Clonal Hematopoiesis Have Increased Heart Disease Risk Following Cancer Treatment

The findings, published Jan. 8 in JAMA Oncology, support the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications. CHIP is a condition, not a disease, characterized by age-related variants in blood stem cells, and it is typically asymptomatic.

January 8, 2026


January 9 2026

January 8 2026

January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025